Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

transcreation

Content team

Exciting updates from our content and strategy team

Cuttsy+Cuttsy celebrates new beginnings with the appointment of Oli Bailey as Strategy Director and recognises team excellence through several well-deserved promotions.

Cuttsy + Cuttsy

- PMLiVE

Pfizer’s Hympavzi granted MHRA approval to treat haemophilia A and B

More than 11,800 people were living with the genetic blood disorders in the UK in 2023/2024

- PMLiVE

BMS receives NICE recommendation for immunotherapy combination in colorectal cancer

Approximately 44,000 people are diagnosed with colorectal cancer in the UK every year

- PMLiVE

AstraZeneca/Daiichi Sankyo’s Enhertu shows promise in first-line HER2-positive breast cancer

Up to 20% of patients with metastatic breast cancer are affected by HER2-positive disease

- PMLiVE

Tackling the antibiotic resistance crisis

With deaths from AMR having increased by over 80% among adults aged 70 and older between 1990 and 2021, and an estimated 4.71 million deaths associated with bacterial AMR in...

- PMLiVE

Free Live Webinar – Patient Recruitment & Retention

Join Innovative Trials and Soglia in this new patient recruitment and retention webinar!

Innovative Trials

search button

The Synergy of SEO and PR in Healthcare Communications

SEO and PR are often seen as separate comms strategies but when used synergistically can help your campaign stand out among the noise. Find out how.

Say Communications

- PMLiVE

Medscape Education Global to Join Biotechs at Swiss Biotech Day

The Medscape Education Global team is excited to announce its participation in Swiss Biotech Day, taking place in Basel from May 5-6. This marks our inaugural attendance at this event,...

Medscape Education

- PMLiVE

Unlock the Future of Patient Recruitment: Learnings from 15 Years of Innovation

How has patient recruitment, retention, and engagement in clinical trials changed over the last 15 years, and what does the future hold?

- PMLiVE

Sanofi/Regeneron’s Dupixent granted FDA approval for chronic spontaneous urticaria

More than 300,000 people in the US are living with uncontrolled cases of the inflammatory skin disease

- PMLiVE

GSK’s Blenrep combinations approved by MHRA to treat multiple myeloma

Approximately 6,500 new cases of the blood cancer are diagnosed in the UK each year

- PMLiVE

FDA approves pre-filled syringe version of argenx’s immune disorder drug Vyvgart

The authorisation will give patients the flexibility to decide when and where they receive treatment

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links